Onassis Holdings Welcomes New Advisory Board Member
Onassis Holdings Corp (OTC:ONSS), a groundbreaking entity in cellular rejuvenation and longevity biotechnology, has made a significant stride in its operational strategy by appointing Esq. Paz Itzhaki-Weinberger to its Advisory Board. This move is expected to bolster the company's expertise in international law, trade, and corporate affairs on a global scale.
Esq. Paz Itzhaki-Weinberger's Expertise
Paz Itzhaki-Weinberger comes with a wealth of knowledge in the realms of technology and law, making him an ideal addition to the Onassis team. He has held prominent roles at Microsoft Corporation and has managed various high-tech ventures. His dual background as an engineer and lawyer provides him with a unique perspective, having practiced at one of Israel's renowned law firms and established PIWLAW, a firm acknowledged as one of the Top 200 Law Firms Worldwide by Legals Finest during its operational years.
Leadership Experience
Currently, Paz serves as the CEO and Chairman of IWC Limited. Previously, he led PatentsFund.com and is actively involved in advising technology startups on crucial matters like IPOs and mergers and acquisitions. He holds dual degrees in Computer Science and Law and is multilingual, speaking English, Hebrew, Japanese, German, and Arabic fluently.
Professional Associations
Paz Itzhaki-Weinberger is well-connected within the legal community, being a member of the Israel Bar Association and the American Bar Association's International Law Division. He is also affiliated with The Law Society of England and Wales. His dedication to technology and law is reflected in his role as a Senior Member of the IEEE and as a board member of the Israel-Britain Chamber of Commerce.
About Onassis Holdings Corp
Onassis Holdings Corp (OTC:ONSS) is at the forefront of biotechnology, focusing on cellular rejuvenation and longevity. With a mission to pivot regenerative medicine innovations into the global market, the company has established strategic partnerships and fosters world-class scientific research to push boundaries in this field.
Future Directions
The appointment of Esq. Itzhaki-Weinberger is expected to enhance Onassis Holdings' strategic initiatives, particularly in navigating complex international trade regulations and expanding its corporate footprint across borders. As the company continues to innovate, it aims to leverage Paz's extensive experience in international dynamics and law to navigate future challenges successfully.
Media Contact Information
For inquiries related to media coverage and investor relations, please contact the Investor Relations Department at Onassis Holdings Corp.
Address: 39 Broadway, New York, NY 10006
Phone: 516-620-6794
Email: info@onassis-holdings.com
Frequently Asked Questions
What is the primary focus of Onassis Holdings Corp?
Onassis Holdings Corp specializes in biotechnology, particularly in the fields of cellular rejuvenation and longevity.
Who is the new member of the Advisory Board?
Esq. Paz Itzhaki-Weinberger has been appointed to the Advisory Board, bringing extensive experience in law and technology.
What experience does Paz Itzhaki-Weinberger have?
Paz has held senior roles in renowned companies, practiced law, and is an accomplished entrepreneur in the tech sector.
How does Onassis Holdings plan to innovate?
Onassis aims to push regenerative medicine to the forefront through strategic collaborations and cutting-edge scientific advancements.
Where can I find more information about the company?
Additional information is available on the company's official website or by contacting their Investor Relations Department.
